Evommune (EVMN) Interest Coverage Ratio (2024 - 2026)
Evommune (EVMN) posted quarterly Interest Coverage Ratio of 0.26 for Q1 2026, up 99.65% year-over-year from 0.13 in Q1 2025, and down 100.04% quarter-over-quarter from 691.07 in Q4 2025.
Powered by 
Analysis
Evommune (EVMN) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported Interest Coverage Ratio for 3 consecutive years, with 0.26 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 99.65% year-over-year to 0.26; the TTM figure through Mar 2026 stood at 0.89 (changed N/A YoY), while the FY2025 annual figure was 1.49, up 98.3% from the prior year.
- Interest Coverage Ratio fell to 0.26 in Q1 2026 per EVMN's latest filing, from 691.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 691.07 in Q4 2025 and bottomed at 3575.67 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 655.59 across 3 years, with a median of 38.54 in 2025.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio soared 119.33% — and 2026, when it surged 99.65%.
- Evommune's Interest Coverage Ratio stood at 3575.67 in 2024, then jumped by 119.33% to 691.07 in 2025, then tumbled by 100.04% to 0.26 in 2026.
- Business Quant data shows EVMN's Interest Coverage Ratio at 0.26 in Q1 2026, 691.07 in Q4 2025, and 1.93 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 1.42 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 10 | Evommune | 446.46 Mn | 245.66 Mn | - | -17,447.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,447.50 |
| Mar 31, 2026 | -5,988.50 |
| Sep 30, 2025 | -1,480.89 |
| Jun 30, 2025 | -851.63 |
| Mar 31, 2025 | -1,156.31 |
| Dec 31, 2024 | 21,454.00 |
| Sep 30, 2024 | -971.59 |